HCPCS Level IIdrugActive
J9227
Inj. isatuximab-irfc 10 mg
BETOS: O1D
Effective: 2020-10-01
Description
Injection, isatuximab-irfc, 10 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Sarclisa
Manufacturer
Sanofi-Aventis U.S. LLC
HCPCS Dosage
10 MG
Billing Units
10.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.